Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a major technological upgrade to Tempus Hub, its AI-enabled smart ...
Mining company Perpetua Resources has secured a $2.9 billion loan from the U.S. Export-Import Bank as the U.S. looks to ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced a new initiative with Bristol Myers Squibb (NYSE: BMY). This collaboration ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The American Petroleum Institute (API) estimated that crude oil inventories in the United States fell by 8.1 million barrels in the week ending May 1. In the week prior, US crude oil inventories fell ...
Investors are watching Tempus AI (NASDAQ:TEM) ahead of first-quarter results due after the close tomorrow. The stock burst into investor consciousness in January 2025 after Nancy Pelosi disclosed a ...
DEDHAM — A Norfolk Superior Court judge cleared the way for Karen Read to use what her lawyers have dubbed racist and homophobic text messages on former Massachusetts State Police trooper Michael ...
Data API Builder helps developers expose database objects through REST and GraphQL without building extensive custom data access code. Steve Jones' Visual Studio Live! San Diego 2026 session will show ...
A Linux variant of the GoGra backdoor uses legitimate Microsoft infrastructure, relying on an Outlook inbox for stealthy payload delivery. The malware is developed by Harvester, an espionage group ...
Digital books have grown in popularity over the past decade, but more Americans still read books in print than in digital formats. Overall, 75% of U.S. adults say they have read all or part of at ...
Tempus AI is a diagnostics and data platform leveraging a large healthcare dataset to inform clinical decision-making. Strong 2025 performance driven by diagnostics growth, oncology re-acceleration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results